Multi-Antibiotic Resistance Carriage in Gut Flora (MARC)

Da Volterra

Status: Completed

Conditions: Intestinal Bacteria Flora Disturbance

Study type: Observational

Funder types: Industry

Identifiers

NCT01591538

ID RCB number : 2011-A01569-32 (Other Identifier)

DAV148-EPI-01

Details and patient eligibility

About

Prevalence Study evaluating the acquisition of carriage of multidrug-resistant Gram-negative bacteria (MDRGNB) in the gut flora in volunteers of French Armed Forces staying from 4 to 6 months outside France.

Full description

Emergence of MDRGN bacteria is blowing worldwide up leading to therapeutical failure in hospitalized patients with severe infections, as well as in outpatients with community-acquired infections such as UTI. Variation in prevalence exists across countries and regions. Travels outside own country of residence, like France, whatever the duration (short or long)or the reason (professional or leisure), are known risk factors for acquiring and disseminating MDRGN bacteria. Digestive carriage of multidrug-resistant Enterobacteriaceae could be a source of infection for the host as well as a source of dissemination. Qualitative and quantitative gut colonization by MDRGNB is poorly studied in non-hospitalized people who stayed for a few months out of France. The total amount of multidrug-resistant Enterobacteriaceae influences the spread of the dissemination. In our knowledge, no clinical study has been carried out to qualify and quantify gut colonization by MDRGNB in volunteers after staying 4-6 months outside country of residence such as France. A specific microbiological method will be evaluated in this study.

Enrollment: 272 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Being older than 18 years
• Have given an informed consent by signing the written consent
• Being able to give a stool sample
• Being member of military forces, supported medically by the French Military Health Services (SSA), and to participate outside mission during 4- 6 months

Exclusion criteria

• Participating in another biomedical study during the study
• Volunteer unable to give informed consent.

Trial design

272 participants in 1 patient group

lifestyle condition